Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.

Article  PubMed  Google Scholar 

McIntyre A, Ganti AK. Lung cancer—a global perspective. J Surg Oncol. 2017;115:550–4.

Article  PubMed  Google Scholar 

Cao M, Chen W. Epidemiology of lung cancer in China. Thorac Cancer. 2019;10:3–7.

Article  PubMed  Google Scholar 

Singal G, Miller PG, Agarwala V, Li G, Kaushik G, Backenroth D, et al. Association of Patient characteristics and tumor genomics with clinical outcomes among patients with non-small cell lung cancer using a clinicogenomic database. J Am Med Assoc. 2019;321:1391–9.

Article  CAS  Google Scholar 

Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. Non-small cell lung cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20:497–530.

Article  PubMed  Google Scholar 

Hanna NH, Robinson AG, Temin S, Baker S Jr, Brahmer JR, Ellis PM, et al. Therapy for stage IV non-small-cell lung cancer with driver alterations: ASCO and OH (CCO) Joint Guideline Update. J Clin Oncol. 2021;39:1040–91.

Article  CAS  PubMed  Google Scholar 

Nguyen CDK, Yi C. YAP/TAZ signaling and resistance to cancer therapy. Trends Cancer. 2019;5:283–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma S, Meng Z, Chen R, Guan KL. The Hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577–604.

Article  CAS  PubMed  Google Scholar 

Wang M, Dai M, Wang D, Xiong W, Zeng Z, Guo C. The regulatory networks of the Hippo signaling pathway in cancer development. J Cancer. 2021;12:6216–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163:811–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rausch V, Hansen CG. The Hippo pathway, YAP/TAZ, and the plasma membrane. Trends Cell Biol. 2020;30:32–48.

Article  CAS  PubMed  Google Scholar 

Dupont S. Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction. Exp Cell Res. 2016;343:42–53.

Article  CAS  PubMed  Google Scholar 

Mohri Z, Del Rio Hernandez A, Krams R. The emerging role of YAP/TAZ in mechanotransduction. J Thorac Dis. 2017;9:E507–9.

Article  PubMed  PubMed Central  Google Scholar 

Park J, Hansen CG. Cellular feedback dynamics and multilevel regulation driven by the hippo pathway. Biochem Soc Trans. 2021;49:1515–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hergovich A, Hemmings BA. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. Biofactors. 2009;35:338–45.

Article  CAS  PubMed  Google Scholar 

Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15:73–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Zhou L, Ling L, Meng X, Chu F, Zhang S, et al. The crosstalk between Hippo-YAP Pathway and innate immunity. Front Immunol. 2020;11:323.

Article  PubMed  PubMed Central  Google Scholar 

Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13:63–79.

Article  CAS  PubMed  Google Scholar 

Song Y, Fu J, Zhou M, Xiao L, Feng X, Chen H, et al. Activated Hippo/Yes-associated protein pathway promotes cell proliferation and anti-apoptosis in endometrial stromal cells of endometriosis. J Clin Endocrinol Metab. 2016;101:1552–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varelas X. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development. 2014;141:1614–26.

Article  CAS  PubMed  Google Scholar 

Davis JR, Tapon N. Hippo signalling during development. Development 2019;146:dev167106.

Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491–505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26:1300–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the roots of cancer. Cancer Cell. 2016;29:783–803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, et al. Comprehensive molecular characterization of the Hippo signaling pathway in cancer. Cell Rep. 2018;25:1304–17.e1305.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huo X, Zhang Q, Liu AM, Tang C, Gong Y, Bian J, et al. Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma. Oncol Rep. 2013;29:840–6.

Article  CAS  PubMed  Google Scholar 

Chen J, Zhang K, Zhi Y, Wu Y, Chen B, Bai J, et al. Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway. Clin Transl Med. 2021;11:e478.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Song Y, Cao M, Fan W, Cui Y, Cui Y, et al. A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma. Clin Transl Med. 2022;12:e836.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma S, Wu Z, Yang F, Zhang J, Johnson RL, Rosenfeld MG, et al. Hippo signalling maintains ER expression and ER(+) breast cancer growth. Nature. 2021;591:E1–10.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Dai Y, Liu S, Zhang WQ, Yang YL, Hang P, Wang H, et al. YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells. Oncotarget. 2017;8:4096–109.

Article  PubMed  Google Scholar 

Zhang Y, Yan S, Chen J, Gan C, Chen D, Li Y, et al. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma. J Cell Mol Med. 2017;21:3718–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang WQ, Dai YY, Hsu PC, Wang H, Cheng L, Yang YL, et al. Targeting YAP in malignant pleural mesothelioma. J Cell Mol Med. 2017;21:2663–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia J, Zeng M, Zhu H, Chen X, Weng Z, Li S. Emerging role of Hippo signalling pathway in bladder cancer. J Cell Mol Med. 2018;22:4–15.

Article  PubMed  Google Scholar 

Kulkarni A, Chang MT, Vissers JHA, Dey A, Harvey KF. The Hippo pathway as a driver of select human cancers. Trends Cancer. 2020;6:781–96.

Article  CAS  PubMed  Google Scholar 

Chen L, Feng P, Peng A, Qiu X, Zhu X, He S, et al. cAMP response element-binding protein and Yes-associated protein form a feedback loop that promotes neurite outgrowth. J Cell Mol Med. 2018;22:374–81.

Article  CAS  PubMed  Google Scholar 

Shao DD, Xue W, Krall EB, Bhutkar A, Piccioni F, Wang X, et al. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell. 2014;158:171–84.

Article  CAS  PubMed  PubMed Central  Google Scholar